Estrogen receptor-positive (ER +) breast cancer is treated with endocrine therapies, although therapeutic resistance almost invariably develops in advanced disease. Using genome-wide CRISPR screens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback